IXAZOMIB

IXAZOMIB was reported 28726 times

IXAZOMIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DUODENAL VARICES 8 0.3333
1 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE DECREASED 9 0.3214
2 CELLULITIS ENTEROCOCCAL 7 0.2917
3 LIGHT CHAIN DISEASE 26 0.1793
4 JC VIRUS CSF TEST POSITIVE 8 0.1455
5 MONOCLONAL IMMUNOGLOBULIN INCREASED 40 0.1399
6 LIGHT CHAIN ANALYSIS INCREASED 116 0.1123
7 PLASMA CELL MYELOMA REFRACTORY 144 0.1076
8 PARAPROTEINAEMIA 33 0.1065
9 PLASMA CELL MYELOMA 3689 0.0945
10 CLONAL HAEMATOPOIESIS 7 0.0909
11 PLASMA CELL MYELOMA RECURRENT 294 0.0904
12 MONOCLONAL IMMUNOGLOBULIN PRESENT 58 0.0763
13 LIGHT CHAIN ANALYSIS ABNORMAL 15 0.0721
14 VARICOPHLEBITIS 9 0.0720
15 ADJUSTED CALCIUM DECREASED 7 0.0660
16 PLASMA CELL LEUKAEMIA 33 0.0550
17 RESPIRATORY TRACT INFECTION BACTERIAL 25 0.0502
18 MORGANELLA INFECTION 12 0.0410
19 PLASMACYTOMA 76 0.0408
20 BRONCHIAL HAEMORRHAGE 12 0.0385
21 PRIMARY AMYLOIDOSIS 9 0.0350
22 NAIL BED INFECTION 8 0.0336
23 IMMUNOGLOBULINS INCREASED 15 0.0322
24 BODY DYSMORPHIC DISORDER 12 0.0320
25 COVID-19 IMMUNISATION 26 0.0311
26 BETA 2 MICROGLOBULIN INCREASED 8 0.0307
27 CHILLBLAINS 8 0.0307
28 NEUTROPHIL COUNT ABNORMAL 85 0.0300
29 BLOOD IMMUNOGLOBULIN G INCREASED 34 0.0280
30 PRODUCT BLISTER PACKAGING ISSUE 29 0.0279
31 FULL BLOOD COUNT INCREASED 32 0.0269
32 VERTEBRAL LESION 13 0.0253
33 AVULSION FRACTURE 7 0.0244
34 BLOOD IMMUNOGLOBULIN A INCREASED 13 0.0241
35 JOINT ANKYLOSIS 12 0.0211
36 CARDIAC AMYLOIDOSIS 23 0.0209
37 CRYPTOSPORIDIOSIS INFECTION 10 0.0190
38 BONE MARROW INFILTRATION 7 0.0181
39 NEOPLASM SKIN 28 0.0180
40 PNEUMONIA INFLUENZAL 21 0.0176
41 RESPIRATORY TRACT INFECTION VIRAL 41 0.0176
42 NAIL RIDGING 9 0.0171
43 CYTOPENIA 206 0.0168
44 PROTEIN TOTAL INCREASED 44 0.0165
45 IMMUNOGLOBULINS DECREASED 22 0.0160
46 AMYLOIDOSIS 27 0.0156
47 BLOOD ALBUMIN ABNORMAL 8 0.0154
48 NEUROPATHY PERIPHERAL 1454 0.0153
49 PRODUCT PHYSICAL ISSUE 299 0.0148
50 FULL BLOOD COUNT DECREASED 297 0.0147
51 PROTEUS INFECTION 10 0.0139
52 KERATOPATHY 21 0.0133
53 ESCHERICHIA BACTERAEMIA 30 0.0127
54 CELL MARKER INCREASED 6 0.0125
55 UPPER RESPIRATORY TRACT INFLAMMATION 15 0.0125
56 CHONDROCALCINOSIS 8 0.0123
57 BRONCHITIS VIRAL 8 0.0119
58 PARAINFLUENZAE VIRUS INFECTION 18 0.0118
59 BLOOD IMMUNOGLOBULIN M INCREASED 7 0.0115
60 METAPNEUMOVIRUS INFECTION 9 0.0115
61 BONE LESION 41 0.0114
62 PAROTITIS 13 0.0112
63 OESOPHAGEAL DISCOMFORT 8 0.0106
64 PERIPHERAL SENSORIMOTOR NEUROPATHY 13 0.0103
65 CAMPYLOBACTER GASTROENTERITIS 6 0.0101
66 HYPOPROTEINAEMIA 19 0.0100
67 BLOOD IMMUNOGLOBULIN M DECREASED 10 0.0100
68 MYOFASCIAL PAIN SYNDROME 7 0.0098
69 OSTEOLYSIS 20 0.0098
70 SPINAL CORD COMPRESSION 37 0.0095
71 PLATELET COUNT DECREASED 1008 0.0094
72 THROMBOCYTOPENIA 1050 0.0094
73 CHOREA 16 0.0093
74 AUTONOMIC NEUROPATHY 9 0.0089
75 PNEUMONIA PNEUMOCOCCAL 13 0.0088
76 PNEUMONIA LEGIONELLA 14 0.0087
77 FEBRILE INFECTION 10 0.0085
78 COVID-19 PNEUMONIA 100 0.0085
79 THERAPY PARTIAL RESPONDER 132 0.0085
80 HAEMOGLOBIN ABNORMAL 54 0.0084
81 VITAMIN B12 DECREASED 24 0.0083
82 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 7 0.0083
83 STREPTOCOCCAL BACTERAEMIA 9 0.0083
84 B-CELL TYPE ACUTE LEUKAEMIA 6 0.0082
85 LISTERIOSIS 9 0.0081
86 PLATELET COUNT ABNORMAL 49 0.0081
87 LABORATORY TEST ABNORMAL 236 0.0080
88 HAEMORRHOIDAL HAEMORRHAGE 39 0.0080
89 VIRAEMIA 11 0.0079
90 PERIPHERAL SENSORY NEUROPATHY 46 0.0079
91 BLOOD CALCIUM ABNORMAL 13 0.0078
92 POLYNEUROPATHY 92 0.0077
93 PLATELET DISORDER 19 0.0075
94 SINUS PAIN 17 0.0073
95 GASTROINTESTINAL TOXICITY 35 0.0073
96 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 10 0.0071
97 PRODUCT PACKAGING ISSUE 66 0.0069
98 PRODUCT PACKAGING DIFFICULT TO OPEN 18 0.0069
99 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 16 0.0069
100 MUSCULOSKELETAL CHEST PAIN 104 0.0067
101 SECONDARY IMMUNODEFICIENCY 8 0.0066
102 NEUTROPHIL COUNT DECREASED 267 0.0065
103 VITILIGO 15 0.0064
104 NEUROLOGICAL SYMPTOM 36 0.0063
105 ARNOLD-CHIARI MALFORMATION 6 0.0063
106 ACTINOMYCOSIS 6 0.0063
107 POST HERPETIC NEURALGIA 9 0.0063
108 ESCHERICHIA SEPSIS 18 0.0062
109 HYPOGEUSIA 12 0.0061
110 LUMBAR VERTEBRAL FRACTURE 28 0.0061
111 HYPOALBUMINAEMIA 47 0.0060
112 PNEUMONIA 1937 0.0060
113 NEUTROPENIC SEPSIS 42 0.0059
114 ADENOCARCINOMA OF COLON 11 0.0059
115 VULVOVAGINAL MYCOTIC INFECTION 23 0.0058
116 HYPERCALCAEMIA 72 0.0058
117 HYPOGAMMAGLOBULINAEMIA 38 0.0058
118 RESPIRATORY TRACT INFECTION 149 0.0057
119 MALIGNANT MELANOMA IN SITU 7 0.0056
120 HICCUPS 45 0.0055
121 HUMERUS FRACTURE 26 0.0054
122 WHITE BLOOD CELL COUNT DECREASED 580 0.0053
123 PNEUMONIA FUNGAL 21 0.0053
124 ENTERITIS INFECTIOUS 9 0.0053
125 GASTROENTERITIS NOROVIRUS 7 0.0053
126 TRIGEMINAL NEURALGIA 21 0.0052
127 ESCHERICHIA URINARY TRACT INFECTION 22 0.0052
128 BRAIN ABSCESS 13 0.0051
129 TUMOUR LYSIS SYNDROME 45 0.0051
130 BONE MARROW TOXICITY 6 0.0051
131 LOWER RESPIRATORY TRACT INFECTION 229 0.0050
132 ADVERSE EVENT 458 0.0050
133 NEUTROPENIA 674 0.0050
134 PULMONARY TUBERCULOSIS 21 0.0049
135 DIARRHOEA 3163 0.0049
136 VENOUS THROMBOSIS LIMB 10 0.0048
137 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0048
138 ENTEROCOLITIS HAEMORRHAGIC 7 0.0047
139 FEBRILE BONE MARROW APLASIA 20 0.0047
140 BRAIN HERNIATION 14 0.0047
141 COMPRESSION FRACTURE 25 0.0047
142 SQUAMOUS CELL CARCINOMA OF SKIN 28 0.0046
143 SARS-COV-2 TEST POSITIVE 61 0.0046
144 SPINAL COMPRESSION FRACTURE 38 0.0046
145 PERIPHERAL SWELLING 708 0.0046
146 KLEBSIELLA INFECTION 23 0.0045
147 TASTE DISORDER 92 0.0045
148 CONSTIPATION 968 0.0044
149 LYMPHOCYTE COUNT DECREASED 78 0.0044
150 ESCHERICHIA INFECTION 36 0.0044
151 SINUS NODE DYSFUNCTION 8 0.0044
152 PNEUMONIA BACTERIAL 40 0.0044
153 HAEMATOTOXICITY 41 0.0043
154 LACTOSE INTOLERANCE 11 0.0043
155 HYPOCALCAEMIA 81 0.0043
156 FAECES SOFT 31 0.0043
157 SPINAL CORD DISORDER 7 0.0043
158 VIRAL UPPER RESPIRATORY TRACT INFECTION 20 0.0042
159 PANCYTOPENIA 234 0.0042
160 JAW FRACTURE 9 0.0042
161 CLOSTRIDIUM DIFFICILE COLITIS 44 0.0041
162 HYPERURICAEMIA 17 0.0041
163 GASTROINTESTINAL MOTILITY DISORDER 22 0.0041
164 ARTHRITIS INFECTIVE 19 0.0041
165 ORAL INFECTION 16 0.0041
166 HERPES ZOSTER 235 0.0041
167 BLOOD COUNT ABNORMAL 62 0.0041
168 BICYTOPENIA 8 0.0041
169 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
170 BLOOD POTASSIUM DECREASED 121 0.0040
171 STEM CELL TRANSPLANT 10 0.0040
172 THERAPY CHANGE 39 0.0040
173 CATARACT 236 0.0040
174 HORDEOLUM 17 0.0039
175 NOCARDIOSIS 10 0.0039
176 GASTROINTESTINAL INFECTION 35 0.0039
177 RHINOVIRUS INFECTION 15 0.0039
178 UPPER RESPIRATORY TRACT INFECTION 178 0.0038
179 DEATH 3317 0.0038
180 DISCOURAGEMENT 9 0.0038
181 CLOSTRIDIUM DIFFICILE INFECTION 84 0.0038
182 GENERAL PHYSICAL CONDITION ABNORMAL 26 0.0038
183 NAIL DISCOLOURATION 15 0.0038
184 DECUBITUS ULCER 31 0.0038
185 PNEUMONIA VIRAL 12 0.0038
186 SPINAL PAIN 44 0.0038
187 LUNG INFECTION 58 0.0037
188 HYPOKALAEMIA 172 0.0037
189 AORTIC VALVE DISEASE 6 0.0037
190 BLOOD TEST ABNORMAL 52 0.0037
191 MYELOSUPPRESSION 133 0.0037
192 RESPIRATORY SYNCYTIAL VIRUS INFECTION 32 0.0037
193 RED BLOOD CELL COUNT DECREASED 105 0.0037
194 BLOOD CALCIUM INCREASED 32 0.0036
195 PERFORMANCE STATUS DECREASED 17 0.0036
196 BLOOD IMMUNOGLOBULIN G DECREASED 9 0.0036
197 MIDDLE EAR EFFUSION 8 0.0036
198 MUSCLE STRAIN 31 0.0036
199 DEMENTIA 100 0.0036
200 PYELONEPHRITIS ACUTE 7 0.0036
201 CELL DEATH 7 0.0035
202 CREATININE RENAL CLEARANCE DECREASED 14 0.0035
203 COVID-19 611 0.0035
204 CORONAVIRUS INFECTION 23 0.0035
205 WHITE BLOOD CELL COUNT ABNORMAL 22 0.0034
206 INFLUENZA 384 0.0034
207 LUMBAR SPINAL STENOSIS 10 0.0034
208 OFF LABEL USE 2976 0.0034
209 GASTRIC INFECTION 13 0.0034
210 CLAVICLE FRACTURE 13 0.0034
211 INGROWING NAIL 8 0.0034
212 ANAEMIA 644 0.0034
213 LYMPHOCYTE COUNT INCREASED 11 0.0034
214 BLOOD MAGNESIUM DECREASED 29 0.0034
215 FULL BLOOD COUNT ABNORMAL 35 0.0033
216 CEREBRAL VENOUS THROMBOSIS 6 0.0033
217 LIP BLISTER 9 0.0033
218 MYELODYSPLASTIC SYNDROME 47 0.0032
219 SPINAL FRACTURE 65 0.0032
220 TOOTH DISORDER 72 0.0032
221 VITAMIN B12 DEFICIENCY 13 0.0032
222 BLOOD CALCIUM DECREASED 36 0.0032
223 MULTIPLE ALLERGIES 25 0.0032
224 AGEUSIA 79 0.0032
225 ORTHOSTATIC HYPOTENSION 55 0.0032
226 SPINAL COLUMN INJURY 7 0.0031
227 ACUTE CORONARY SYNDROME 26 0.0031
228 CARDIAC FAILURE 252 0.0031
229 LIP PAIN 9 0.0031
230 SEPTIC SHOCK 136 0.0031
231 PULMONARY THROMBOSIS 34 0.0031
232 SEPSIS 346 0.0031
233 PAPILLOEDEMA 14 0.0031
234 THROMBOTIC MICROANGIOPATHY 30 0.0031
235 PERIARTHRITIS 7 0.0031
236 HYPERTRIGLYCERIDAEMIA 18 0.0031
237 BACTERIAL SEPSIS 10 0.0031
238 PHARYNGITIS 38 0.0031
239 RASH MACULAR 107 0.0031
240 EYELID DISORDER 7 0.0030
241 ADVERSE DRUG REACTION 271 0.0030
242 HAEMOGLOBIN DECREASED 309 0.0030
243 VENTRICULAR ARRHYTHMIA 11 0.0030
244 ANXIETY DISORDER 10 0.0030
245 RENAL IMPAIRMENT 251 0.0030
246 PERIPHERAL COLDNESS 41 0.0030
247 GINGIVITIS 16 0.0030
248 RIB FRACTURE 61 0.0030
249 COLITIS ISCHAEMIC 20 0.0030
250 CARDIAC DYSFUNCTION 11 0.0030
251 DECREASED IMMUNE RESPONSIVENESS 29 0.0030
252 BASAL CELL CARCINOMA 46 0.0029
253 BLOOD CREATINE INCREASED 13 0.0029
254 URINARY HESITATION 7 0.0029
255 VARICELLA 7 0.0029
256 PROTEIN TOTAL DECREASED 11 0.0029
257 PIGMENTATION DISORDER 18 0.0029
258 NO ADVERSE EVENT 525 0.0029
259 BACK PAIN 673 0.0029
260 DEHYDRATION 385 0.0029
261 INFECTION 417 0.0029
262 HYPOAESTHESIA 430 0.0029
263 BACTERAEMIA 34 0.0029
264 URINE OUTPUT DECREASED 25 0.0029
265 MUSCLE RUPTURE 11 0.0028
266 RASH PRURITIC 153 0.0028
267 GASTROENTERITIS 41 0.0028
268 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0028
269 PATHOLOGICAL FRACTURE 14 0.0028
270 SEASONAL ALLERGY 39 0.0028
271 RENAL DISORDER 128 0.0027
272 BLOOD PHOSPHORUS DECREASED 10 0.0027
273 FEMORAL NECK FRACTURE 14 0.0027
274 PRODUCT DOSE OMISSION ISSUE 802 0.0027
275 PRODUCT TEMPERATURE EXCURSION ISSUE 14 0.0027
276 ATAXIA 32 0.0027
277 HEART RATE ABNORMAL 15 0.0027
278 MYOCLONUS 32 0.0027
279 DRUG INTOLERANCE 257 0.0027
280 EYE INFECTION 30 0.0027
281 RASH MACULO-PAPULAR 59 0.0026
282 LIMB DISCOMFORT 82 0.0026
283 SUDDEN DEATH 28 0.0026
284 LYMPHOPENIA 37 0.0026
285 DYSAESTHESIA 8 0.0026
286 HYPERNATRAEMIA 13 0.0026
287 RHINITIS 21 0.0026
288 PRODUCT DOSE OMISSION 170 0.0026
289 THROMBOSIS 209 0.0026
290 TOXIC SKIN ERUPTION 26 0.0026
291 HYPOPHOSPHATAEMIA 19 0.0026
292 PELVIC FRACTURE 20 0.0026
293 CLUMSINESS 7 0.0026
294 LOCALISED INFECTION 62 0.0026
295 ACCIDENTAL EXPOSURE TO PRODUCT 264 0.0026
296 PARAESTHESIA 402 0.0026
297 INCONTINENCE 27 0.0026
298 DEPRESSIVE SYMPTOM 9 0.0026
299 DECREASED APPETITE 589 0.0025
300 HOSPICE CARE 25 0.0025
301 FEBRILE NEUTROPENIA 166 0.0025
302 BODY TEMPERATURE INCREASED 51 0.0025
303 RASH 1089 0.0025
304 NASOPHARYNGITIS 460 0.0025
305 BONE PAIN 146 0.0025
306 ACUTE LYMPHOCYTIC LEUKAEMIA 7 0.0025
307 FATIGUE 1921 0.0025
308 UPPER LIMB FRACTURE 49 0.0025
309 BRONCHOPULMONARY ASPERGILLOSIS 19 0.0024
310 BLOOD CREATININE INCREASED 160 0.0024
311 DYSPNOEA EXERTIONAL 92 0.0024
312 ASTHENIA 917 0.0024
313 SKIN ATROPHY 14 0.0024
314 STAPHYLOCOCCAL SEPSIS 12 0.0024
315 FRACTURE 46 0.0024
316 PRODUCTIVE COUGH 116 0.0024
317 ENTEROCOLITIS 14 0.0024
318 ILEUS 30 0.0024
319 BRONCHITIS 178 0.0024
320 SWELLING OF EYELID 15 0.0024
321 NEURALGIA 58 0.0024
322 UROSEPSIS 22 0.0024
323 OSTEONECROSIS OF JAW 59 0.0024
324 VIRAL INFECTION 79 0.0024
325 RENAL FAILURE 314 0.0024
326 VOMITING 1110 0.0024
327 NEOPLASM RECURRENCE 8 0.0024
328 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
329 CARDIOTOXICITY 21 0.0024
330 ABSCESS LIMB 10 0.0023
331 INTERVERTEBRAL DISC DISORDER 10 0.0023
332 THERAPY NON-RESPONDER 105 0.0023
333 NAUSEA 1847 0.0023
334 BONE MARROW DISORDER 7 0.0023
335 ACUTE KIDNEY INJURY 354 0.0023
336 BONE MARROW FAILURE 47 0.0023
337 MUSCLE SPASMS 424 0.0023
338 URINARY TRACT INFECTION 394 0.0023
339 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
340 TUMOUR MARKER INCREASED 11 0.0023
341 GASTRIC DISORDER 78 0.0023
342 OSTEOMYELITIS 41 0.0023
343 FLUID RETENTION 115 0.0023
344 DISEASE PROGRESSION 267 0.0023
345 ERYTHEMA MULTIFORME 21 0.0022
346 EPISTAXIS 168 0.0022
347 ELECTROLYTE IMBALANCE 26 0.0022
348 MALNUTRITION 25 0.0022
349 SKIN INFECTION 25 0.0022
350 FACIAL BONES FRACTURE 8 0.0022
351 RECURRENT CANCER 9 0.0022
352 SKIN DISCOLOURATION 101 0.0022
353 ARTHRITIS BACTERIAL 9 0.0022
354 RASH PAPULAR 49 0.0022
355 SPINAL STENOSIS 9 0.0022
356 INCREASED TENDENCY TO BRUISE 20 0.0022
357 CHROMATURIA 49 0.0022
358 BURNING SENSATION 152 0.0022
359 PRODUCT DISTRIBUTION ISSUE 20 0.0022
360 HOSPITALISATION 331 0.0022
361 ATRIAL FIBRILLATION 209 0.0021
362 ACUTE PULMONARY OEDEMA 12 0.0021
363 PYREXIA 735 0.0021
364 CELLULITIS 107 0.0021
365 COGNITIVE DISORDER 99 0.0021
366 HEPATOCELLULAR INJURY 30 0.0021
367 SKIN LESION 58 0.0021
368 MENINGITIS 14 0.0021
369 HIP FRACTURE 67 0.0021
370 ILLNESS 214 0.0021
371 STAPHYLOCOCCAL BACTERAEMIA 9 0.0021
372 RASH VESICULAR 10 0.0021
373 ONYCHOMYCOSIS 9 0.0020
374 OEDEMA PERIPHERAL 250 0.0020
375 BLOOD CREATININE ABNORMAL 7 0.0020
376 HYPERVOLAEMIA 10 0.0020
377 FALL 672 0.0020
378 HYPERTRANSAMINASAEMIA 14 0.0020
379 GENERAL PHYSICAL HEALTH DETERIORATION 232 0.0020
380 HEPATIC ENZYME ABNORMAL 10 0.0020
381 MASS 28 0.0020
382 LIVER FUNCTION TEST INCREASED 43 0.0020
383 BALANCE DISORDER 173 0.0020
384 FLUID INTAKE REDUCED 10 0.0020
385 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 15 0.0020
386 GASTROINTESTINAL DISORDER 179 0.0020
387 CONFUSIONAL STATE 320 0.0020
388 URINE ABNORMALITY 9 0.0020
389 NERVE INJURY 22 0.0020
390 DRUG TOLERANCE 10 0.0020
391 ABDOMINAL HERNIA 9 0.0020
392 BOWEL MOVEMENT IRREGULARITY 15 0.0020
393 HAEMORRHOIDS 38 0.0019
394 LOCALISED OEDEMA 9 0.0019
395 CARDIAC FAILURE CONGESTIVE 156 0.0019
396 FEELING COLD 54 0.0019
397 RASH GENERALISED 50 0.0019
398 GASTRITIS EROSIVE 9 0.0019
399 SKIN NECROSIS 10 0.0019
400 TRANSIENT ISCHAEMIC ATTACK 65 0.0019
401 PNEUMONIA ASPIRATION 48 0.0019
402 CUTANEOUS VASCULITIS 7 0.0019
403 HYPONATRAEMIA 108 0.0019
404 DERMATITIS ALLERGIC 24 0.0019
405 SPINAL DISORDER 18 0.0019
406 LEUKOPENIA 95 0.0019
407 GOUT 34 0.0019
408 EYE SWELLING 70 0.0019
409 BACTERIAL INFECTION 35 0.0019
410 PLEURAL EFFUSION 114 0.0019
411 FOOD POISONING 10 0.0019
412 SKIN ULCER 48 0.0019
413 METASTATIC NEOPLASM 8 0.0019
414 CONTUSION 178 0.0018
415 DEEP VEIN THROMBOSIS 120 0.0018
416 FACE INJURY 7 0.0018
417 BONE CANCER 8 0.0018
418 MULTIPLE ORGAN DYSFUNCTION SYNDROME 52 0.0018
419 HYPERTHERMIA 14 0.0018
420 JAW DISORDER 10 0.0018
421 RESPIRATORY FAILURE 133 0.0018
422 TOOTH INFECTION 24 0.0018
423 PULMONARY EMBOLISM 172 0.0018
424 INGUINAL HERNIA 11 0.0018
425 APHONIA 25 0.0018
426 CONJUNCTIVITIS 33 0.0018
427 BODY HEIGHT DECREASED 19 0.0018
428 SKIN TOXICITY 10 0.0018
429 JOINT SWELLING 213 0.0018
430 SCIATICA 28 0.0018
431 DISEASE COMPLICATION 8 0.0017
432 ISCHAEMIA 8 0.0017
433 SYNCOPE 174 0.0017
434 CYSTITIS 55 0.0017
435 ENTERITIS 11 0.0017
436 LOWER LIMB FRACTURE 33 0.0017
437 MALIGNANT MELANOMA 23 0.0017
438 DIARRHOEA HAEMORRHAGIC 16 0.0017
439 ABDOMINAL DISCOMFORT 287 0.0017
440 MALAISE 749 0.0017
441 UNEVALUABLE EVENT 129 0.0017
442 HYPERGLYCAEMIA 62 0.0017
443 SQUAMOUS CELL CARCINOMA 16 0.0017
444 GENERALISED OEDEMA 21 0.0017
445 EMBOLISM 14 0.0017
446 BLOOD POTASSIUM INCREASED 27 0.0017
447 COLITIS 63 0.0017
448 SKIN MASS 11 0.0016
449 DERMATITIS ACNEIFORM 10 0.0016
450 DRY EYE 82 0.0016
451 FEEDING DISORDER 33 0.0016
452 HYPERKALAEMIA 57 0.0016
453 LIMB INJURY 44 0.0016
454 GASTROENTERITIS VIRAL 29 0.0016
455 APPENDICITIS 15 0.0016
456 BACK DISORDER 26 0.0016
457 NEUROTOXICITY 28 0.0016
458 EATING DISORDER 34 0.0016
459 IMMUNE SYSTEM DISORDER 21 0.0016
460 LEUKAEMIA 15 0.0016
461 CHOLECYSTITIS ACUTE 9 0.0016
462 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
463 FEMUR FRACTURE 49 0.0016
464 CYTOMEGALOVIRUS VIRAEMIA 7 0.0016
465 HYPERSOMNIA 45 0.0016
466 MOUTH SWELLING 9 0.0016
467 SKIN DISORDER 52 0.0016
468 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
469 WOUND INFECTION 17 0.0016
470 DIVERTICULITIS 43 0.0016
471 VISION BLURRED 213 0.0015
472 APHTHOUS ULCER 12 0.0015
473 FAILURE TO THRIVE 8 0.0015
474 HYPOVOLAEMIA 9 0.0015
475 COUGH 429 0.0015
476 KIDNEY INFECTION 30 0.0015
477 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
478 PULMONARY OEDEMA 68 0.0015
479 PAIN IN EXTREMITY 447 0.0015
480 SINUS DISORDER 30 0.0015
481 BLOOD ALBUMIN DECREASED 12 0.0015
482 GINGIVAL PAIN 12 0.0015
483 RENAL FUNCTION TEST ABNORMAL 7 0.0015
484 ACUTE RESPIRATORY FAILURE 29 0.0015
485 CEREBRAL ATROPHY 6 0.0015
486 ATRIAL FLUTTER 12 0.0015
487 CARDIAC FAILURE ACUTE 10 0.0015
488 URINARY RETENTION 50 0.0015
489 BLOOD DISORDER 12 0.0015
490 BLEPHARITIS 6 0.0015
491 SWELLING 139 0.0015
492 INSOMNIA 395 0.0015
493 LUNG DISORDER 72 0.0015
494 DRUG ERUPTION 26 0.0015
495 GAIT INABILITY 49 0.0015
496 FAECALOMA 8 0.0015
497 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
498 RESPIRATION ABNORMAL 10 0.0014
499 ANAL INCONTINENCE 13 0.0014
500 DIZZINESS POSTURAL 14 0.0014
501 DELIRIUM 50 0.0014
502 OEDEMA 78 0.0014
503 ADVERSE REACTION 19 0.0014
504 BLOOD IRON DECREASED 17 0.0014
505 C-REACTIVE PROTEIN INCREASED 52 0.0014
506 ORAL PAIN 32 0.0014
507 BONE DISORDER 26 0.0014
508 GASTRIC ULCER 27 0.0014
509 PAPULE 10 0.0014
510 CEREBROVASCULAR ACCIDENT 240 0.0014
511 MUCOSAL INFLAMMATION 37 0.0014
512 DYSPEPSIA 139 0.0014
513 CARDIAC DISORDER 132 0.0014
514 COLON CANCER 21 0.0014
515 SUBDURAL HAEMATOMA 20 0.0014
516 CYTOKINE RELEASE SYNDROME 28 0.0014
517 HYPOAESTHESIA ORAL 21 0.0014
518 GASTRIC HAEMORRHAGE 16 0.0014
519 DECREASED ACTIVITY 15 0.0014
520 LACRIMATION INCREASED 42 0.0014
521 SKIN LACERATION 15 0.0014
522 NERVOUS SYSTEM DISORDER 43 0.0014
523 NAIL DISORDER 12 0.0014
524 ABDOMINAL DISTENSION 143 0.0014
525 HYPOPHAGIA 35 0.0014
526 PHLEBITIS 7 0.0014
527 ORAL CANDIDIASIS 18 0.0014
528 ENDOCARDITIS 7 0.0014
529 BLOOD PRESSURE ABNORMAL 27 0.0014
530 APPETITE DISORDER 9 0.0014
531 SINUSITIS 138 0.0013
532 RHINORRHOEA 87 0.0013
533 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
534 IMMUNODEFICIENCY 20 0.0013
535 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 70 0.0013
536 STOMATITIS 81 0.0013
537 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 240 0.0013
538 GINGIVAL BLEEDING 18 0.0013
539 HEPATIC FUNCTION ABNORMAL 49 0.0013
540 HYPOXIA 46 0.0013
541 NEOPLASM 15 0.0013
542 CARDIOMEGALY 16 0.0013
543 SMALL INTESTINAL OBSTRUCTION 16 0.0013
544 MALIGNANT NEOPLASM PROGRESSION 133 0.0013
545 MUSCULAR WEAKNESS 147 0.0013
546 HIP SURGERY 7 0.0013
547 FUNGAL INFECTION 43 0.0013
548 ACUTE MYOCARDIAL INFARCTION 38 0.0013
549 CHILLS 151 0.0013
550 ABDOMINAL PAIN UPPER 265 0.0013
551 VITAMIN D DECREASED 11 0.0013
552 BRAIN FOG 20 0.0013
553 SLUGGISHNESS 13 0.0013
554 DRY SKIN 170 0.0013
555 FLATULENCE 72 0.0013
556 FURUNCLE 10 0.0013
557 CHOLECYSTITIS 15 0.0013
558 HERNIA 24 0.0012
559 WEIGHT DECREASED 346 0.0012
560 PERIORBITAL SWELLING 7 0.0012
561 NECK PAIN 69 0.0012
562 SWELLING FACE 80 0.0012
563 ORAL DISORDER 9 0.0012
564 LETHARGY 70 0.0012
565 WOUND 34 0.0012
566 MEMORY IMPAIRMENT 167 0.0012
567 TOOTHACHE 22 0.0012
568 HYPOACUSIS 52 0.0012
569 FEELING JITTERY 23 0.0012
570 RALES 7 0.0012
571 INCREASED APPETITE 23 0.0012
572 ALTERED STATE OF CONSCIOUSNESS 26 0.0012
573 FAECES DISCOLOURED 26 0.0012
574 CHOLESTASIS 23 0.0012
575 BRAIN NEOPLASM 11 0.0012
576 PNEUMOCYSTIS JIROVECII PNEUMONIA 12 0.0012
577 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
578 PAROSMIA 9 0.0012
579 RASH ERYTHEMATOUS 57 0.0012
580 PRODUCT ADMINISTRATION ERROR 24 0.0012
581 ASPIRATION 13 0.0012
582 TROPONIN INCREASED 9 0.0012
583 PLEURISY 7 0.0012
584 NEPHROPATHY 11 0.0012
585 TREMOR 195 0.0012
586 FLANK PAIN 11 0.0012
587 MYOPATHY 10 0.0012
588 LARGE INTESTINE POLYP 8 0.0012
589 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
590 ANGINA PECTORIS 33 0.0012
591 THERAPY CESSATION 59 0.0011
592 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
593 HAEMATEMESIS 29 0.0011
594 CYTOMEGALOVIRUS INFECTION 19 0.0011
595 LIP SWELLING 38 0.0011
596 SCAB 13 0.0011
597 MOUTH ULCERATION 24 0.0011
598 INTERNAL HAEMORRHAGE 13 0.0011
599 DIZZINESS 567 0.0011
600 BLOOD LACTATE DEHYDROGENASE INCREASED 18 0.0011
601 EAR PAIN 22 0.0011
602 CANDIDA INFECTION 19 0.0011
603 DYSPNOEA 636 0.0011
604 JOINT INJURY 24 0.0011
605 GAIT DISTURBANCE 215 0.0011
606 ISCHAEMIC STROKE 20 0.0011
607 BLADDER DISORDER 11 0.0011
608 POST PROCEDURAL INFECTION 9 0.0011
609 PNEUMONITIS 30 0.0011
610 PRODUCT PRESCRIBING ISSUE 24 0.0011
611 BLOOD PRESSURE DECREASED 73 0.0011
612 ARRHYTHMIA 52 0.0011
613 GASTROINTESTINAL PAIN 12 0.0011
614 CHEST PAIN 202 0.0011
615 HAEMATOCHEZIA 60 0.0011
616 RESPIRATORY DISTRESS 30 0.0011
617 NERVE COMPRESSION 10 0.0011
618 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
619 HAEMATURIA 37 0.0011
620 FEELING DRUNK 8 0.0011
621 AGRANULOCYTOSIS 20 0.0011
622 ORAL HERPES 21 0.0011
623 PLATELET COUNT INCREASED 14 0.0011
624 DYSGEUSIA 79 0.0011
625 PULMONARY CONGESTION 14 0.0011
626 FACIAL PARALYSIS 9 0.0011
627 FOOT FRACTURE 20 0.0011
628 PETECHIAE 11 0.0011
629 EAR INFECTION 28 0.0011
630 WEIGHT FLUCTUATION 11 0.0011
631 CARDIAC VALVE DISEASE 6 0.0010
632 OROPHARYNGEAL PAIN 97 0.0010
633 QUALITY OF LIFE DECREASED 14 0.0010
634 HEAD INJURY 33 0.0010
635 DEVICE RELATED INFECTION 16 0.0010
636 PYELONEPHRITIS 9 0.0010
637 PERICARDIAL EFFUSION 24 0.0010
638 RESPIRATORY DISORDER 31 0.0010
639 EYE DISORDER 34 0.0010
640 DYSSTASIA 30 0.0010
641 GROIN PAIN 9 0.0010
642 NEPHROLITHIASIS 47 0.0010
643 CEREBRAL INFARCTION 25 0.0010
644 PULMONARY HAEMORRHAGE 8 0.0010
645 ECCHYMOSIS 7 0.0010
646 BLISTER 57 0.0010
647 PERICARDITIS 17 0.0010
648 DYSPHONIA 59 0.0010
649 FACIAL PAIN 9 0.0010
650 FACE OEDEMA 17 0.0010
651 POLLAKIURIA 42 0.0010
652 LOSS OF CONSCIOUSNESS 129 0.0010
653 MELAENA 22 0.0010
654 DUODENAL ULCER 7 0.0010
655 END STAGE RENAL DISEASE 18 0.0010
656 GLAUCOMA 19 0.0010
657 POOR QUALITY SLEEP 21 0.0010
658 MULTIPLE FRACTURES 16 0.0010
659 HAEMOPTYSIS 27 0.0010
660 ANOSMIA 14 0.0010
661 MICTURITION URGENCY 11 0.0010
662 EYE DISCHARGE 10 0.0010
663 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 46 0.0010
664 AMNESIA 62 0.0010
665 INTERSTITIAL LUNG DISEASE 46 0.0009
666 SKIN EXFOLIATION 80 0.0009
667 BLOOD URINE PRESENT 18 0.0009
668 FEELING ABNORMAL 227 0.0009
669 CARDIOMYOPATHY 14 0.0009
670 MUSCLE ATROPHY 12 0.0009
671 CEREBRAL DISORDER 7 0.0009
672 PRESYNCOPE 23 0.0009
673 ALANINE AMINOTRANSFERASE INCREASED 58 0.0009
674 PRODUCT USE ISSUE 175 0.0009
675 MUSCULOSKELETAL DISCOMFORT 16 0.0009
676 CARDIAC FLUTTER 6 0.0009
677 VISUAL IMPAIRMENT 115 0.0009
678 HYPOTENSION 186 0.0009
679 HAEMATOMA 24 0.0009
680 PRODUCT PRESCRIBING ERROR 22 0.0009
681 DEAFNESS 24 0.0009
682 PULMONARY HYPERTENSION 19 0.0009
683 LIGAMENT SPRAIN 9 0.0009
684 RENAL INJURY 27 0.0009
685 IMMUNOSUPPRESSION 8 0.0009
686 ANKLE FRACTURE 14 0.0009
687 SOMNOLENCE 182 0.0009
688 HEAD DISCOMFORT 16 0.0009
689 MENTAL STATUS CHANGES 25 0.0009
690 EYE HAEMORRHAGE 12 0.0009
691 HEPATIC FAILURE 27 0.0009
692 GASTROINTESTINAL INFLAMMATION 7 0.0009
693 EMPHYSEMA 9 0.0009
694 BRONCHIECTASIS 6 0.0009
695 PRURITUS 342 0.0009
696 INFLUENZA LIKE ILLNESS 73 0.0009
697 VERTIGO 54 0.0009
698 TOOTH ABSCESS 9 0.0009
699 ARTHROPATHY 49 0.0009
700 RESPIRATORY TRACT CONGESTION 14 0.0009
701 ABSCESS 14 0.0009
702 INTESTINAL OBSTRUCTION 33 0.0009
703 DRY MOUTH 71 0.0009
704 ACCIDENTAL OVERDOSE 32 0.0009
705 SENSORY LOSS 7 0.0009
706 BLOOD THYROID STIMULATING HORMONE INCREASED 8 0.0009
707 MYALGIA 147 0.0009
708 TREATMENT NONCOMPLIANCE 47 0.0009
709 POST PROCEDURAL HAEMORRHAGE 10 0.0009
710 ARTHRALGIA 357 0.0009
711 HEPATOTOXICITY 19 0.0009
712 ACUTE RESPIRATORY DISTRESS SYNDROME 15 0.0008
713 JOINT STIFFNESS 22 0.0008
714 CEREBRAL HAEMORRHAGE 30 0.0008
715 NIGHT SWEATS 27 0.0008
716 MACULAR DEGENERATION 10 0.0008
717 EJECTION FRACTION DECREASED 13 0.0008
718 SLEEP DISORDER 59 0.0008
719 DISORIENTATION 33 0.0008
720 PHARYNGITIS STREPTOCOCCAL 9 0.0008
721 ABDOMINAL PAIN 193 0.0008
722 TINNITUS 38 0.0008
723 OCULAR HYPERAEMIA 39 0.0008
724 JAUNDICE 22 0.0008
725 RENAL TUBULAR NECROSIS 8 0.0008
726 DYSURIA 30 0.0008
727 SKIN HYPERPIGMENTATION 7 0.0008
728 SINUS CONGESTION 11 0.0008
729 DEPRESSED MOOD 43 0.0008
730 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
731 CHEST DISCOMFORT 83 0.0008
732 DIPLOPIA 21 0.0008
733 SKIN SWELLING 7 0.0008
734 NEOPLASM PROGRESSION 28 0.0008
735 HAEMORRHAGE INTRACRANIAL 12 0.0008
736 NASAL CONGESTION 47 0.0008
737 INTENTIONAL PRODUCT USE ISSUE 70 0.0008
738 BLOOD SODIUM DECREASED 15 0.0008
739 HAEMORRHAGE 83 0.0008
740 SKIN CANCER 17 0.0008
741 RESPIRATORY RATE INCREASED 7 0.0008
742 ARTHRITIS 62 0.0008
743 WEIGHT INCREASED 176 0.0008
744 SUBARACHNOID HAEMORRHAGE 8 0.0008
745 GALLBLADDER DISORDER 14 0.0008
746 MUSCULOSKELETAL PAIN 41 0.0008
747 WHITE BLOOD CELL COUNT INCREASED 30 0.0008
748 HAEMOLYTIC ANAEMIA 7 0.0008
749 NEOPLASM MALIGNANT 52 0.0008
750 OSTEOARTHRITIS 33 0.0008
751 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
752 EYELID OEDEMA 9 0.0008
753 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
754 ACUTE MYELOID LEUKAEMIA 12 0.0008
755 INFUSION RELATED REACTION 51 0.0008
756 DRUG DOSE OMISSION 127 0.0008
757 PANIC ATTACK 28 0.0008
758 PARAESTHESIA ORAL 11 0.0008
759 PAIN 466 0.0008
760 STAPHYLOCOCCAL INFECTION 25 0.0008
761 MYOCARDIAL INFARCTION 132 0.0008
762 FLUID OVERLOAD 11 0.0008
763 PERSONALITY CHANGE 7 0.0008
764 BLOOD PRESSURE INCREASED 115 0.0008
765 BREAST PAIN 8 0.0007
766 HEPATIC CIRRHOSIS 14 0.0007
767 ARTERIOSCLEROSIS 7 0.0007
768 ADRENAL INSUFFICIENCY 9 0.0007
769 EXTRA DOSE ADMINISTERED 30 0.0007
770 INFLAMMATION 38 0.0007
771 URTICARIA 123 0.0007
772 EYE INFLAMMATION 7 0.0007
773 GASTROOESOPHAGEAL REFLUX DISEASE 59 0.0007
774 PROSTATIC SPECIFIC ANTIGEN INCREASED 10 0.0007
775 DENTAL CARIES 8 0.0007
776 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
777 LIVER DISORDER 32 0.0007
778 RECTAL HAEMORRHAGE 31 0.0007
779 ORAL DISCOMFORT 10 0.0007
780 GASTROINTESTINAL HAEMORRHAGE 60 0.0007
781 PHARYNGEAL SWELLING 7 0.0007
782 CARDIAC ARREST 59 0.0007
783 THYROID DISORDER 11 0.0007
784 OCULAR DISCOMFORT 8 0.0007
785 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
786 MOBILITY DECREASED 51 0.0007
787 PARALYSIS 10 0.0007
788 DYSPHAGIA 66 0.0007
789 TOXICITY TO VARIOUS AGENTS 117 0.0007
790 NODULE 9 0.0007
791 INITIAL INSOMNIA 7 0.0007
792 ASCITES 20 0.0007
793 MUSCLE TIGHTNESS 11 0.0007
794 TENDERNESS 7 0.0007
795 PAIN IN JAW 19 0.0007
796 NERVOUSNESS 35 0.0007
797 DIABETES MELLITUS 51 0.0007
798 SNEEZING 15 0.0007
799 WRIST FRACTURE 8 0.0007
800 THROAT TIGHTNESS 18 0.0007
801 ERYTHEMA 136 0.0007
802 NOCTURIA 8 0.0007
803 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
804 SPINAL OPERATION 8 0.0006
805 HUNGER 9 0.0006
806 CYST 8 0.0006
807 SKIN REACTION 9 0.0006
808 FEELING HOT 39 0.0006
809 PRODUCT USE COMPLAINT 10 0.0006
810 ABDOMINAL PAIN LOWER 16 0.0006
811 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 45 0.0006
812 BLOOD BILIRUBIN INCREASED 17 0.0006
813 SLEEP APNOEA SYNDROME 12 0.0006
814 ROAD TRAFFIC ACCIDENT 26 0.0006
815 LIVER FUNCTION TEST ABNORMAL 18 0.0006
816 PRODUCT AVAILABILITY ISSUE 14 0.0006
817 LIVER INJURY 15 0.0006
818 MYOCARDITIS 7 0.0006
819 BEDRIDDEN 8 0.0006
820 MANIA 10 0.0006
821 HYPERHIDROSIS 78 0.0006
822 BLOOD GLUCOSE INCREASED 114 0.0006
823 OXYGEN SATURATION DECREASED 34 0.0006
824 DRUG INEFFECTIVE 797 0.0006
825 HYPERSENSITIVITY 112 0.0006
826 RESTLESSNESS 22 0.0006
827 VASCULITIS 7 0.0006
828 MOOD SWINGS 19 0.0006
829 PAIN OF SKIN 16 0.0006
830 MOVEMENT DISORDER 19 0.0006
831 ACUTE HEPATIC FAILURE 8 0.0006
832 DRUG RESISTANCE 15 0.0006
833 ELECTROCARDIOGRAM QT PROLONGED 21 0.0006
834 CHOLELITHIASIS 19 0.0006
835 HEART RATE INCREASED 57 0.0006
836 HYPOMAGNESAEMIA 8 0.0006
837 URINARY INCONTINENCE 17 0.0006
838 THERAPY INTERRUPTED 41 0.0006
839 BLINDNESS UNILATERAL 8 0.0006
840 EYE PRURITUS 19 0.0006
841 RETCHING 12 0.0006
842 SEIZURE 65 0.0006
843 THERAPEUTIC RESPONSE DECREASED 34 0.0006
844 HEADACHE 351 0.0006
845 THIRST 10 0.0006
846 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
847 FREQUENT BOWEL MOVEMENTS 15 0.0006
848 APATHY 8 0.0005
849 ROTATOR CUFF SYNDROME 7 0.0005
850 BLOOD GLUCOSE DECREASED 26 0.0005
851 HEART RATE DECREASED 19 0.0005
852 HIATUS HERNIA 7 0.0005
853 PULMONARY MASS 8 0.0005
854 THINKING ABNORMAL 10 0.0005
855 HEART RATE IRREGULAR 12 0.0005
856 HOT FLUSH 40 0.0005
857 SHOCK 12 0.0005
858 ERUCTATION 10 0.0005
859 SPEECH DISORDER 27 0.0005
860 MOOD ALTERED 14 0.0005
861 METASTASES TO LIVER 9 0.0005
862 VISUAL ACUITY REDUCED 17 0.0005
863 CENTRAL NERVOUS SYSTEM LESION 7 0.0005
864 ALOPECIA 100 0.0005
865 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
866 HAEMATOCRIT DECREASED 10 0.0005
867 HEPATIC ENZYME INCREASED 34 0.0005
868 RESTLESS LEGS SYNDROME 9 0.0005
869 STEVENS-JOHNSON SYNDROME 11 0.0005
870 BURSITIS 6 0.0005
871 SINUS TACHYCARDIA 7 0.0005
872 HYPERTENSION 104 0.0005
873 BLINDNESS 20 0.0005
874 WHEEZING 29 0.0005
875 BLOOD GLUCOSE ABNORMAL 9 0.0005
876 VENTRICULAR TACHYCARDIA 8 0.0005
877 PHOTOSENSITIVITY REACTION 8 0.0005
878 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
879 MENTAL DISORDER 21 0.0005
880 COAGULOPATHY 8 0.0005
881 CARDIO-RESPIRATORY ARREST 20 0.0005
882 DERMATITIS 10 0.0005
883 PANCREATITIS 25 0.0005
884 PROSTATE CANCER 38 0.0005
885 CHRONIC KIDNEY DISEASE 35 0.0005
886 ANXIETY 130 0.0005
887 EOSINOPHILIA 8 0.0005
888 GASTRITIS 12 0.0005
889 EYE IRRITATION 26 0.0005
890 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
891 ENCEPHALOPATHY 11 0.0004
892 EYE PAIN 25 0.0004
893 PNEUMOTHORAX 7 0.0004
894 PALLOR 12 0.0004
895 LUNG NEOPLASM MALIGNANT 18 0.0004
896 SENSORY DISTURBANCE 7 0.0004
897 TOOTH LOSS 9 0.0004
898 APHASIA 13 0.0004
899 CARPAL TUNNEL SYNDROME 6 0.0004
900 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 11 0.0004
901 UNRESPONSIVE TO STIMULI 11 0.0004
902 DISCOMFORT 26 0.0004
903 DYSARTHRIA 16 0.0004
904 LYMPHADENOPATHY 15 0.0004
905 TREATMENT FAILURE 35 0.0004
906 BRONCHOSPASM 6 0.0004
907 IRRITABLE BOWEL SYNDROME 9 0.0004
908 BLOOD UREA INCREASED 7 0.0004
909 MEDICATION ERROR 23 0.0004
910 MENTAL IMPAIRMENT 10 0.0004
911 DYSTONIA 8 0.0004
912 HALLUCINATION 31 0.0004
913 CIRCULATORY COLLAPSE 7 0.0004
914 SKIN FISSURES 8 0.0004
915 THROAT IRRITATION 18 0.0004
916 BRADYCARDIA 21 0.0004
917 DEPRESSION 90 0.0004
918 BLOOD CHOLESTEROL INCREASED 18 0.0004
919 ANGER 13 0.0004
920 MUSCULOSKELETAL STIFFNESS 33 0.0004
921 HEPATIC STEATOSIS 7 0.0004
922 PHOTOPHOBIA 7 0.0004
923 OSTEONECROSIS 12 0.0004
924 TRANSAMINASES INCREASED 8 0.0004
925 GLOSSODYNIA 8 0.0004
926 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
927 PANCREATITIS ACUTE 8 0.0004
928 FLUSHING 36 0.0004
929 DISABILITY 7 0.0004
930 CONDITION AGGRAVATED 107 0.0004
931 PRESCRIBED UNDERDOSE 7 0.0004
932 ERECTILE DYSFUNCTION 9 0.0004
933 PANCREATIC CARCINOMA 10 0.0003
934 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 8 0.0003
935 PALPITATIONS 40 0.0003
936 PSYCHOTIC DISORDER 10 0.0003
937 DISTURBANCE IN ATTENTION 18 0.0003
938 BLOOD PRESSURE FLUCTUATION 8 0.0003
939 IRRITABILITY 20 0.0003
940 PRURITUS GENERALISED 7 0.0003
941 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
942 SWOLLEN TONGUE 10 0.0003
943 ACNE 24 0.0003
944 INTENTIONAL DOSE OMISSION 9 0.0003
945 CARDIOVASCULAR DISORDER 8 0.0003
946 METABOLIC ACIDOSIS 10 0.0003
947 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
948 LACTIC ACIDOSIS 10 0.0003
949 IMPAIRED HEALING 10 0.0003
950 TYPE 2 DIABETES MELLITUS 10 0.0003
951 DYSKINESIA 12 0.0003
952 OSTEOPOROSIS 12 0.0003
953 AGITATION 21 0.0003
954 ASTHMA 32 0.0003
955 HYPOTHYROIDISM 9 0.0003
956 TACHYCARDIA 25 0.0003
957 GASTRIC CANCER 7 0.0003
958 COMA 13 0.0003
959 HYPOGLYCAEMIA 13 0.0003
960 CORONARY ARTERY DISEASE 8 0.0003
961 ILL-DEFINED DISORDER 16 0.0003
962 BREAST CANCER 24 0.0003
963 SURGERY 15 0.0003
964 DRUG EFFECT INCOMPLETE 9 0.0002
965 PRODUCT USE IN UNAPPROVED INDICATION 61 0.0002
966 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
967 PRODUCT STORAGE ERROR 21 0.0002
968 RHABDOMYOLYSIS 10 0.0002
969 OVERDOSE 49 0.0002
970 EMOTIONAL DISORDER 7 0.0002
971 ANGIOEDEMA 10 0.0002
972 SKIN BURNING SENSATION 16 0.0002
973 BLADDER CANCER 13 0.0002
974 MIGRAINE 21 0.0002
975 INJURY 15 0.0002
976 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
977 UNDERDOSE 13 0.0002
978 DRUG INTERACTION 28 0.0002
979 ECZEMA 9 0.0002
980 DISEASE RECURRENCE 8 0.0002
981 ANAPHYLACTIC REACTION 8 0.0001
982 PRODUCT SUBSTITUTION ISSUE 8 0.0001
983 DRUG EFFECT DECREASED 7 0.0001
984 INCORRECT DOSE ADMINISTERED 26 0.0001
985 SUICIDAL IDEATION 10 0.0001
986 PRODUCT QUALITY ISSUE 14 0.0001
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 14 0.0001
988 EMOTIONAL DISTRESS 7 0.0001
989 PSORIASIS 7 0.0001